Regulatory Genomics and Human Disease Laboratory

In the regulatory genomics laboratory we use genomic technologies to understand the regulation of cell type, chromatin and human disease.

The New

2021.12 - New publication: Single cells and transposable element heterogeneity in stem cells and development in Cell Regeneration

2021.11 - Collaborators publication: Wang Yong and co. publish about computationally determining the optimal set for cell sorting experiments in Briefings in Bioinformatics

2021.08 - New publication: Isaac publishes about how transposable element sequence fragments make up a substantial part of the pluripotent transcriptome in Nucleic Acids Research.

2021.05 - Collaborator's publication: Zhao Xiaoying and co. publish their analysis of the chromatin accessibility in Primordial Germ Cells. Read more in Stem Cell Reports.

2021.03 - New publication: With He Jiangping, and Chen Jiekai for the GRMH-GDL we describe a new method to analyse transposable elements in single-cell data in Nature Communications

2021.02 - New publication: We publish our review on chromatin and epigenetic rearrangements in embryonic cell types in Frontiers in Cell and Developmental Biology

2020.12 - Collaborator's publication: Yao Hongjie and Song Yawei publish their work on UV damage and BRD5 in Frontiers in Molecular Biosciences

2020.10 - Collaborator's publication: Qin Baoming and Huang Yinghua publish about the role of KLF4 and JMJD3 in reprogramming in Nature Communications